Patents Assigned to Chalmers Ventures AB
  • Publication number: 20210003662
    Abstract: A distributed FMCW radar communication system for interference mitigation in an ego unit comprising at least one RadCom unit arranged for radar sensing in a radar mode and for data communication in a communication mode with at least one target unit by switching between the radar mode and the communication mode in time and using separate frequency bands for the radar mode and the communication mode, using a random medium access technique for communication, where the ego unit comprises a plurality of RadCom units and a control unit adapted to control the plurality of RadCom units to use different starting times and frequency bands based on at least one received control message by means of communication during a radar frame duration (Tf) received by means of the data communication, where the starting times of different FMCW radars are separated sufficiently so as they are orthogonal.
    Type: Application
    Filed: July 3, 2019
    Publication date: January 7, 2021
    Applicant: Chalmers Ventures AB
    Inventors: Canan AYDOGDU, Henk WYMEERSCH
  • Publication number: 20170268066
    Abstract: The present invention relates to a method of screening for cancer in a subject, said method comprising determining the level in a sample of an expression product of one or more genes of a certain metabolic network of reactions and/or determining the level in a sample of a metabolite related to an expression product of one or more of said genes, wherein said sample has been obtained from said subject. Methods of treating cancer and kits are also provided.
    Type: Application
    Filed: March 14, 2017
    Publication date: September 21, 2017
    Applicant: Chalmers Ventures AB
    Inventors: Francesco GATTO, Jens NIELSEN, Almut SCHULZE
  • Publication number: 20170254811
    Abstract: The present invention relates to a method of screening for renal cell carcinoma in a subject, said method comprising determining the level and/or chemical composition of one or both of the glycosaminoglycans (GAGs) chondroitin sulfate (CS) and heparan sulfate (HS) in a body fluid sample, wherein said sample has been obtained from said subject.
    Type: Application
    Filed: March 7, 2017
    Publication date: September 7, 2017
    Applicant: Chalmers Ventures AB
    Inventors: Francesco GATTO, Jens NIELSEN